What We're Reading: Page 283
Industry reads hand-picked by our editors
May 01, 2018
Apr 30, 2018
-
The New York Times
Injecting drugs can ruin a heart. How many second chances should a user get?
-
CBS News
CRISPR: The gene-editing tool revolutionizing biomedical research
-
Reuters
Hong Kong scrambles for talent in battle for Nasdaq's biotech crown
-
The Wall Street Journal
Cracking the code of life — at light speed
Apr 27, 2018
Apr 26, 2018
-
Bloomberg Gadfly
GSK tries to fix pharma on a budget
-
Politico
Big pharma’s battle for the benchmark
-
Scientific American
Winning the war on tuberculosis
Apr 25, 2018
Apr 24, 2018
Apr 23, 2018
-
Nikkei Asian Review
Why Takeda has bet the farm on Shire
-
Financial Times
US companies count costs and benefits of Trump tax law
-
The New York Times
The problem with miracle cancer cures
Previous
